Nova Leap Health Corp. Re-engages Acquisition Program With Closing of Strategic Acquisition in Massachusetts
Nova Leap Health Corp. Re-engages Acquisition Program With Closing of Strategic Acquisition in Massachusetts
About Nova LeapNOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES
不用於在美國傳播或分發給美國新聞通訊社
HALIFAX, Nova Scotia, May 06, 2024 (GLOBE NEWSWIRE) -- NOVA LEAP HEALTH CORP. (TSXV: NLH) ("Nova Leap" or "the Company"), a growing home health care organization, is pleased to announce that it has completed the strategic acquisition of a home care business with operations in Massachusetts. The execution of the definitive agreement and related information pertaining to this acquisition was previously announced on April 26, 2024.
新斯科舍省哈利法克斯，2024 年 5 月 6 日（環球新聞專線）— NOVA LEAP HEALTH CORP.多倫多證券交易所股票代碼：NLH）（“Nova Leap” 或 “公司”）是一家成長中的家庭醫療保健組織，很高興地宣佈，它已經完成了對一家在馬薩諸塞州開展業務的家庭護理公司的戰略收購。與本次收購有關的最終協議和相關信息的執行已於2024年4月26日宣佈。
"We're pleased to re-engage our acquisition program by completing our first acquisition of 2024," said Chris Dobbin, President & CEO of Nova Leap. "This acquisition complements our existing businesses in Massachusetts and is part of our strategy of expanding our footprint in the region. We're looking forward to working with this tremendous group of individuals as we plan further expansion."
Nova Leap總裁兼首席執行官克里斯·多賓表示：“我們很高興通過完成2024年的首次收購來重新參與我們的收購計劃。”“此次收購補充了我們在馬薩諸塞州的現有業務，是我們擴大該地區足跡的戰略的一部分。在我們計劃進一步擴張時，我們期待與這群龐大的人合作。”
About Nova Leap
Nova Leap is an acquisitive home health care services company operating in one of the fastest-growing industries in the U.S. & Canada. The Company performs a vital role within the continuum of care with an individual and family centered focus, particularly those requiring dementia care. Nova Leap achieved the #42 and #2 ranking on the 2021 and 2020 Report on Business ranking of Canada's Top Growing Companies and the #10 Ranking in the 2019 TSX Venture 50 in the Clean Technology & Life Sciences sector. The Company is geographically diversified with operations in 8 different U.S. states within the New England, Southeastern, South-Central and Midwest regions as well as Nova Scotia, Canada.
關於 Nova Le
Nova Leap 是一家收購型家庭醫療保健服務公司，業務範圍是美國和加拿大增長最快的行業之一。公司以個人和家庭爲中心，在持續的護理中發揮着至關重要的作用，尤其是那些需要癡呆症護理的患者。Nova Leap在《2021年和2020年加拿大成長型公司商業報告》排名中獲得了 #42 和 #2 排名，在清潔技術和生命科學領域的2019年多倫多證券交易所風險投資50強中獲得了#10 排名。該公司的地域多元化，業務遍及美國新英格蘭、東南部、中南部和中西部地區以及加拿大新斯科舍省的8個不同州。
FORWARD LOOKING INFORMATION:
前瞻性信息：
Certain information in this press release may contain forward-looking statements, such as statements regarding future expansions and cost savings and plans regarding future acquisitions and business growth, including anticipated annualized revenue or annualized recurring revenue run rate growth and anticipated consolidated Adjusted EBITDA margins. This information is based on current expectations and assumptions, including assumptions described elsewhere in this release and those concerning general economic and market conditions, availability of working capital necessary for conducting Nova Leap's operations, availability of desirable acquisition targets and financing to fund such acquisitions, and Nova Leap's ability to integrate its acquired businesses and maintain previously achieved service hour and revenue levels, that are subject to significant risks and uncertainties that are difficult to predict. Actual results might differ materially from results suggested in any forward-looking statements. Risks that could cause results to differ from those stated in the forward-looking statements in this release include the impact of the COVID-19 pandemic or any recurrence, including staff and supply shortages, regulatory changes affecting the home care industry or government programs utilized by the Company, other unexpected increases in operating costs and competition from other service providers. All forward-looking statements, including any financial outlook or future-oriented financial information, contained in this press release are made as of the date of this release and included for the purpose of providing information about management's current expectations and plans relating to the future, and these statements may not be appropriate for other purposes. The Company assumes no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those reflected in the forward-looking statements unless and until required by securities laws applicable to the Company. Additional information identifying risks and uncertainties is contained in the Company's filings with the Canadian securities regulators, which filings are available at .
本新聞稿中的某些信息可能包含前瞻性陳述，例如有關未來擴張和成本節約的陳述，以及有關未來收購和業務增長的計劃，包括預期的年化收入或年化經常性收入增長率以及預期的合併調整後息稅折舊攤銷前利潤率。這些信息基於當前的預期和假設，包括本新聞稿其他地方描述的假設以及與總體經濟和市場狀況、開展Nova Leap運營所需的營運資金的可用性、理想收購目標和融資的可用性，以及Nova Leap整合其收購業務和維持先前實現的服務時間和收入水平的能力有關的假設，這些假設都存在難以預測的重大風險和不確定性。實際結果可能與任何前瞻性陳述中建議的結果存在重大差異。可能導致結果與本新聞稿前瞻性陳述中陳述的結果不同的風險包括 COVID-19 疫情或任何復發的影響，包括人員和供應短缺、影響家庭護理行業或公司使用的政府計劃的監管變化、運營成本的其他意外增加以及來自其他服務提供商的競爭。本新聞稿中包含的所有前瞻性陳述，包括任何財務展望或面向未來的財務信息，均自本新聞稿發佈之日起作出，其包含的目的是提供有關管理層當前預期和未來計劃的信息，這些陳述可能不適用於其他目的。除非適用於公司的證券法有要求，否則公司沒有義務更新前瞻性陳述，也沒有義務更新實際業績可能與前瞻性陳述中反映的結果不同的原因。識別風險和不確定性的其他信息包含在公司向加拿大證券監管機構提交的文件中，這些文件可在以下網址查閱 。
CAUTIONARY STATEMENT:
警示聲明：
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
多倫多證券交易所風險投資交易所及其監管服務提供商（該術語在多倫多證券交易所風險交易所的政策中定義）均不對本新聞稿的充分性或準確性承擔責任。
CONTACT: For further information: Chris Dobbin, CPA, ICD.D Director, President and CEO Nova Leap Health Corp. T: 902 401 9480 E: cdobbin@novaleaphealth.com
聯繫人：欲了解更多信息：Chris Dobbin，註冊會計師、ICD.D 董事、總裁兼首席執行官 Nova Leap Health Corp. T: 902 401 9480 E: cdobbin@novaleaphealth.com
譯文內容由第三人軟體翻譯。
